BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3515364)

  • 21. The challenge of colorectal cancer.
    Mason AY
    Proc R Soc Med; 1973 Dec; 66(12):1177-8. PubMed ID: 4777045
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraperitoneal immunotherapy of peritoneal carcinomatosis.
    Freedman RS; Lenzi R; Kudelka AP; Lawrence DD; Rosenblum M; Platsoucas CD
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):121-40. PubMed ID: 9681251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Corynebacterium parvum on human effector cells in peripheral blood.
    Gill PG; Waller CA; Clarke J; Darley J; Morris PJ
    Dev Biol Stand; 1977 Apr 13-15; 38():455-60. PubMed ID: 608538
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy in colorectal cancer.
    Wallack MK
    Mo Med; 1981 Jan; 78(1):23-5. PubMed ID: 7219405
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoclonal antibodies specific immunotherapy of gastrointestinal tumors.
    Douillard JY; Lehur PA; Vignoud J; Blottière H; Maurel C; Thedrez P; Kremer M; Le Mevel B
    Hybridoma; 1986 Jul; 5 Suppl 1():S139-49. PubMed ID: 3527945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphokine-activated killer cells: in vitro and in vivo studies.
    Mazumder A
    Lymphokine Res; 1985; 4(3):215-20. PubMed ID: 3897730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multidisciplinary therapy for peritoneal dissemination using peritonectomy].
    Yonemura Y; Kinoshita K; Takahashi S; Bando E; Kawamura S; Maeda A; Nagata S; Uesaka K; Yamaguchi S; Tsubosa Y; Sasaki T; Endo Y; Tanaka M; Sawa T; Matsuki N
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2178-83. PubMed ID: 12484031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic progress in digestive cancerology. VI. Treatment of colorectal cancer].
    Gerard A
    Med Chir Dig; 1980; 9(2):147-54. PubMed ID: 6157058
    [No Abstract]   [Full Text] [Related]  

  • 30. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy for colo-rectal cancer.
    Wilson RE
    Ann Chir Gynaecol; 1983; 72(6):290-2. PubMed ID: 6364949
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of tumor growth inhibition.
    Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
    [No Abstract]   [Full Text] [Related]  

  • 34. Making use of the primary tumour.
    Baars A; Buter J; Pinedo HM
    Bioessays; 2003 Jan; 25(1):79-86. PubMed ID: 12508286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of patients with cancer.
    Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
    Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
    [No Abstract]   [Full Text] [Related]  

  • 36. Ex vivo activation of killer monocytes (AKM) and their application to the treatment of human cancer.
    Stevenson HC; Lacerna LV; Sugarbaker PH
    J Clin Apher; 1988; 4(2-3):118-21. PubMed ID: 3135291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for colon cancer: a historical perspective.
    Grem J
    J Natl Cancer Inst; 2004 Aug; 96(15):1116-7. PubMed ID: 15292377
    [No Abstract]   [Full Text] [Related]  

  • 38. Adoptive immunotherapy.
    Sznol M; Urba WJ
    Cancer Chemother Biol Response Modif; 1993; 14():227-48. PubMed ID: 8312104
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
    Rosenberg SA
    J Biol Response Mod; 1984 Oct; 3(5):501-11. PubMed ID: 6389777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of colorectal cancer.
    Påhlman L
    Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.